U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953622) titled 'Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale' on Aug. 19, 2024.

Brief Summary: To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.

Study Start Date: Jan. 01, 2024

Study Type: OBSERVATIONAL

Condition: Migraine Patent Foramen Ovale

Intervention: DRUG: Conservative treatment

Receive no antipaletet drug treatment and surgery

DRUG: Antipaletet dr...